EP1012155A4 - HUMAN ORIGIN DECOUPLING PROTEIN 3 - Google Patents

HUMAN ORIGIN DECOUPLING PROTEIN 3

Info

Publication number
EP1012155A4
EP1012155A4 EP19980923517 EP98923517A EP1012155A4 EP 1012155 A4 EP1012155 A4 EP 1012155A4 EP 19980923517 EP19980923517 EP 19980923517 EP 98923517 A EP98923517 A EP 98923517A EP 1012155 A4 EP1012155 A4 EP 1012155A4
Authority
EP
European Patent Office
Prior art keywords
human origin
decoupling protein
decoupling
protein
origin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19980923517
Other languages
German (de)
French (fr)
Other versions
EP1012155A1 (en
Inventor
Qingyun Liu
Fang Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9716886.8A external-priority patent/GB9716886D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP1012155A1 publication Critical patent/EP1012155A1/en
Publication of EP1012155A4 publication Critical patent/EP1012155A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP19980923517 1997-05-20 1998-05-19 HUMAN ORIGIN DECOUPLING PROTEIN 3 Withdrawn EP1012155A4 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US4717997P 1997-05-20 1997-05-20
GBGB9716886.8A GB9716886D0 (en) 1997-08-08 1997-08-08 Human uncoupling protein 3
GB9716886 1997-08-08
US6914197P 1997-12-09 1997-12-09
US69141P 1997-12-09
PCT/US1998/010215 WO1998052958A1 (en) 1997-05-20 1998-05-19 Human uncoupling protein 3
US47179P 2008-04-23

Publications (2)

Publication Number Publication Date
EP1012155A1 EP1012155A1 (en) 2000-06-28
EP1012155A4 true EP1012155A4 (en) 2002-11-04

Family

ID=27268968

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19980923517 Withdrawn EP1012155A4 (en) 1997-05-20 1998-05-19 HUMAN ORIGIN DECOUPLING PROTEIN 3

Country Status (4)

Country Link
EP (1) EP1012155A4 (en)
JP (1) JP2002502240A (en)
CA (1) CA2289945A1 (en)
WO (1) WO1998052958A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0980433A1 (en) 1997-05-07 2000-02-23 Novartis-Erfindungen Verwaltungsgesellschaft m.b.H. Uncoupling protein homologue: ucp 3
JP4709383B2 (en) 1998-09-22 2011-06-22 ジェネンテック， インコーポレイテッド UCP4
ATE492640T1 (en) 1998-11-30 2011-01-15 Genentech Inc RELEASING PROTEIN 5 - UCP5
US7342102B2 (en) 1998-11-30 2008-03-11 Genentech, Inc. Uncoupling protein 5 (UCP5)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998039432A1 (en) * 1997-03-05 1998-09-11 Smithkline Beecham Plc Polynucleotides and polypeptides belonging to the uncoupling proteins family
WO1998050542A1 (en) * 1997-05-07 1998-11-12 Novartis Ag Uncoupling protein homologue: ucp 3

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998039432A1 (en) * 1997-03-05 1998-09-11 Smithkline Beecham Plc Polynucleotides and polypeptides belonging to the uncoupling proteins family
WO1998050542A1 (en) * 1997-05-07 1998-11-12 Novartis Ag Uncoupling protein homologue: ucp 3

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BOSS O ET AL: "UNCOUPLING PROTEIN-3: A NEW MEMBER OF THE MITOCHONDRIAL CARRIER FAMILY WITH TISSUE-SPECIFIC EXPRESSION", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 408, no. 1, 1997, pages 39 - 42, XP002067895, ISSN: 0014-5793 *
DATABASE SWALLPROT [online] XP002214359, Database accession no. p55916 *
DATABASE SWALLPROT [online] XP002214361, Database accession no. p56501 *
MATSUDA J ET AL: "Cloning of rat uncoupling protein-3 and uncoupling protein-2 cDNAs: their gene expression in rats fed high-fat diet", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 418, no. 1-2, 24 November 1997 (1997-11-24), pages 200 - 204, XP004261541, ISSN: 0014-5793 *
See also references of WO9852958A1 *
YOSHITOMI H ET AL: "Cloning of mouse uncoupling protein 3 cDNA and 5'-flanking region, and its genetic map", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, vol. 215, no. 1, July 1998 (1998-07-01), pages 77 - 84, XP004149231, ISSN: 0378-1119 *

Also Published As

Publication number Publication date
JP2002502240A (en) 2002-01-22
CA2289945A1 (en) 1998-11-26
EP1012155A1 (en) 2000-06-28
WO1998052958A1 (en) 1998-11-26

Similar Documents

Publication Publication Date Title
EP1100869A4 (en) 98 HUMAN SECRETATED PROTEINS
EP1088071A4 (en) 94 SACRED HUMAN PROTEINS
DE69834967D1 (en) System for tissue mapping and ablation
PT1032396E (en) STERILIZATION OF GLUCOCORTICOESTEROIDS
NO983364L (en) Consensus Proteins
EP1040117A4 (en) 110 HUMAN SECRETATED PROTEINS
DE69839989D1 (en) IMAGE-CONTROLLED SURGICAL SYSTEM
DE69828963D1 (en) WIRSTOFFABGE AND GENTHERAPY SYSTEM
EP1006927A4 (en) PERFECTIONAL DENTAL OR ORTHOPEDIC IMPLANT SYSTEM
EP1095159A4 (en) BONE MORPHOGENETIC PROTEIN
BR9707151A (en) Product application set and body deodorant application set
EP1244683A4 (en) 21 HUMAN SUCKED PROTEINS
ID24669A (en) DOLASTATIN 15
EP1044211A4 (en) 36 HUMAN SECRETATED PROTEINS
EP1019091A4 (en) 50 HUMAN SECRETED PROTEINS
EP1097199A4 (en) 71 HUMAN SECRETATED PROTEINS
EP0832125A4 (en) HUMAN G PROTEIN RECEPTOR HGBER32
EP1124850A4 (en) 12 HUMAN SECRETATED PROTEINS
DK0779035T3 (en) Modified whey protein
FI970979A7 (en) Modified human C3 proteins
EP1062236A4 (en) 31 HUMAN SECRETED PROTEINS
ITMI941469A0 (en) PROTEINS WITH ANTI-CANCER ACTIVITY
EP0832122A4 (en) HUMAN G PROTEIN HPRAJ70 RECEPTOR
EP1042674A4 (en) 148 HUMAN SUCKED PROTEINS
EP1018551A4 (en) MEGSINE PROTEIN

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991220

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20021104

17Q First examination report despatched

Effective date: 20040701

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050103